<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Shigella infection: Epidemiology, clinical manifestations, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Shigella infection: Epidemiology, clinical manifestations, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Shigella infection: Epidemiology, clinical manifestations, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rabia Agha, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marcia B Goldberg, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen B Calderwood, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elinor L Baron, MD, DTMH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 25, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Shigella
         </em>
         species are a common cause of diarrhea worldwide.
        </p>
        <p>
         Issues related to the epidemiology, microbiology, clinical manifestations, complications, and diagnosis of
         <em>
          Shigella
         </em>
         infection will be reviewed here. Issues related to treatment and prevention of
         <em>
          Shigella
         </em>
         infection are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6003.html" rel="external">
          "Shigella infection: Treatment and prevention in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3831696636">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H3913480757">
         <span class="h2">
          Burden of disease
         </span>
        </p>
        <p class="headingAnchor" id="H1689102883">
         <span class="h3">
          Worldwide
         </span>
         <span class="headingEndMark">
          —
         </span>
         Worldwide, 188 million cases of
         <em>
          Shigella
         </em>
         occur annually, with 164,000 associated deaths [
         <a href="#rid1">
          1
         </a>
         ].
         <em>
          Shigella
         </em>
         is the most common cause of invasive (bloody) diarrhea among children in resource-limited settings [
         <a href="#rid2">
          2
         </a>
         ]. In a study among children &lt;6 years of age in the Peruvian Amazon, an incidence of 0.34 episodes of
         <em>
          Shigella
         </em>
         diarrhea per year was observed [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         In many resource-limited settings,
         <em>
          S. flexneri
         </em>
         is the predominant species [
         <a href="#rid4">
          4
         </a>
         ].
         <em>
          S. sonnei
         </em>
         is the second most prevalent; however,
         <em>
          S. sonnei
         </em>
         appears to be emerging in economically transitional regions [
         <a href="#rid5">
          5
         </a>
         ]. As an example,
         <em>
          S. sonnei
         </em>
         has become the most common isolate in Vietnam [
         <a href="#rid6">
          6,7
         </a>
         ] and could become the predominant species in other parts of Southeast Asia. (See
         <a class="local">
          'Microbiology'
         </a>
         below.)
        </p>
        <p>
         <em>
          S. dysenteriae
         </em>
         is rarely isolated in surveillance; its decline is likely due to improvements in sanitation and antimicrobial access [
         <a href="#rid5">
          5
         </a>
         ].
         <em>
          S. boydii
         </em>
         infections are uncommon outside the Indian subcontinent [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2140526160">
         <span class="h3">
          United States
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the United States,
         <em>
          Shigella
         </em>
         cases occur most commonly from June to October, and predominantly affects children [
         <a href="#rid8">
          8
         </a>
         ].
         <em>
          Shigella
         </em>
         infection is associated with poverty (incidence rate ratio 3.6) and crowded living conditions (incidence rate ratio 1.8) [
         <a href="#rid9">
          9
         </a>
         ]. In 2022, the incidence of shigellosis in the United States was 4.9 cases per 100,000 population, about three to four times less frequent than
         <em>
          Campylobacter
         </em>
         or
         <em>
          Salmonella
         </em>
         infection [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Most cases of shigellosis in the United States are caused by
         <em>
          Shigella sonnei
         </em>
         (&gt;75 percent),
         <em>
          Shigella flexneri
         </em>
         is the next most frequent isolate [
         <a href="#rid11">
          11,12
         </a>
         ]. Disease caused by
         <em>
          S. sonnei
         </em>
         tends to be less severe than that caused by
         <em>
          S. flexneri
         </em>
         .
        </p>
        <p>
         In the early 1900s,
         <em>
          Shigella dysenteriae
         </em>
         1 (the
         <em>
          Shiga
         </em>
         bacillus) was the most common isolate in the United States and Europe, but is now rare. In the United States,
         <em>
          S
         </em>
         .
         <em>
          dysenteriae
         </em>
         1 infection is generally limited to imported cases from Mexico and Central America [
         <a href="#rid13">
          13
         </a>
         ] or from laboratory contamination [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="local">
          'Microbiology'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3590632510">
         <span class="h2">
          Transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Shigella
         </em>
         organisms can survive transit through the stomach since they are less susceptible to acid than other bacteria. For this reason, the inoculum required for the development of clinical disease is quite low; as few as 10 to 100 organisms can cause disease [
         <a href="#rid15">
          15
         </a>
         ]. Humans are the only natural reservoir for disease.
        </p>
        <p>
         <em>
          Shigella
         </em>
         bacteria are transmitted by the fecal-oral route; this includes transmission within households or between close contacts, transmission through sexual contact, and outbreaks related to contaminated food and water:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Household or close contact transmission
         </strong>
         – Fecal-oral transmission from individuals with symptomatic infection is the most common mechanism of transmission. The secondary attack rate for family members or caregivers in the same household as the index case is 20 percent, and is highest when the index case is between one and four years of age [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In resource-rich settings, outbreaks occur most commonly in child care centers and in settings with crowded living conditions such as residential institutions [
         <a href="#rid17">
          17,18
         </a>
         ]. Issues related to prevention of infection in child care centers are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6003.html" rel="external">
          "Shigella infection: Treatment and prevention in children", section on 'School or daycare'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sexual transmission
         </strong>
         – Outbreaks of shigellosis have occurred among men who have sex with men (MSM) [
         <a href="#rid19">
          19-22
         </a>
         ]. In one study including 151 episodes of gastroenteritis among MSM in which a pathogen was identified, 31 percent involved
         <em>
          Shigella
         </em>
         [
         <a href="#rid23">
          23
         </a>
         ]. In resource-rich settings, intercontinental transmission as well as domestically-acquired
         <em>
          Shigella
         </em>
         infection have been reported among with MSM [
         <a href="#rid21">
          21,24-26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Outbreaks of extensively drug resistant (XDR) strains of
         <em>
          Shigella
         </em>
         have been reported worldwide, including in the United States. Approximately 80 percent of XDR cases have occurred in men, many of whom reported male-to-male sexual contact [
         <a href="#rid27">
          27-29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults", section on 'Antibiotic resistance'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contaminated food, drinking water, or recreational water
         </strong>
         – Outbreaks occur due to common source contamination of food, drinking water, or recreational water [
         <a href="#rid30">
          30
         </a>
         ]. Fecal contamination can occur during cultivation of produce; raw vegetables are the most common mode of foodborne transmission implicated in outbreaks [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In one review of untreated recreational water outbreaks in the United States between 2000 and 2014, 14 of the 90 outbreaks with confirmed etiology (15 percent) were caused by
         <em>
          Shigella
         </em>
         [
         <a href="#rid32">
          32
         </a>
         ]. Updated information on foodborne outbreaks may be found on websites maintained by the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Ffoodnet%2Freports%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLP%2F2QvaEIA4SKO0gOEuf1VgY0YkeS8eQxq4ypPiI8NSzyeT%2FmnPtuFxMsoc8brVKag%3D%3D&amp;TOPIC_ID=2718" target="_blank">
          United States Centers for Disease Control and Prevention
         </a>
         and the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Frecalls-outbreaks-emergencies%2Foutbreaks-foodborne-illness&amp;token=RnGqCfYGTGgdz5387EFWwvy4g0FBsVH2%2F8GNTYjMB5LrJLowNdHBE3AHH5VQdHvjZEGstInrU%2FzZFkdijUOFBBVMo%2FciHvaLQZ9RU37rpBQ%3D&amp;TOPIC_ID=2718" target="_blank">
          US Food and Drug Administration
         </a>
         .
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3825829978">
         <span class="h2">
          Drug resistance
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Shigella
         </em>
         species have emerged with resistance to several antibiotics. The United States Centers for Disease Control (CDC) defines XDR
         <em>
          Shigella
         </em>
         bacteria as strains with resistance to
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         ,
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         , and
         <a class="drug drug_general" data-topicid="8737" href="/z/d/drug information/8737.html" rel="external">
          ampicillin
         </a>
         .
        </p>
        <p>
         Issues related to antimicrobial resistance are discussed further separately. (See
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults", section on 'Antibiotic resistance'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H313454323">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Shigella
         </em>
         are nonmotile, facultatively anaerobic, gram-negative rods. They are members of the family Enterobacteriaceae, genus
         <em>
          Shigella
         </em>
         .
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Species
         </strong>
         – There are four species of
         <em>
          Shigella
         </em>
         :
         <em>
          S. dysenteriae
         </em>
         (serogroup A),
         <em>
          S. flexneri
         </em>
         (serogroup B),
         <em>
          S. boydii
         </em>
         (serogroup C), and
         <em>
          S. sonnei
         </em>
         (serogroup D). Groups A, B, and C cannot be distinguished biochemically;
         <em>
          S. sonnei
         </em>
         can be differentiated from the other serogroups by the expression of ornithine decarboxylase.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The microbiology of shigellosis varies with geography. (See
         <a class="local">
          'Burden of disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The spectrum of disease severity varies depending on the infecting species. (See
         <a class="local">
          'Signs and symptoms'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Toxin elaboration
         </strong>
         –
         <em>
          Shigella
         </em>
         strains elaborate three distinct enterotoxins: the virulence plasmid-encoded ShET2 (produced by all four species) [
         <a href="#rid33">
          33
         </a>
         ], chromosomally-encoded ShET1 (produced by
         <em>
          S. flexneri
         </em>
         2a) [
         <a href="#rid34">
          34-36
         </a>
         ], and Shiga toxin (produced by
         <em>
          S. dysenteriae
         </em>
         1) [
         <a href="#rid37">
          37
         </a>
         ].
         <em>
          S. sonnei
         </em>
         and
         <em>
          S. flexneri
         </em>
         isolates that produce Shiga toxin have been identified [
         <a href="#rid38">
          38,39
         </a>
         ]. These enterotoxins induce intestinal secretion of solutes and water. With the exception of Shiga toxin, the contribution of each of these toxins to the disease process is probably minor, since nontoxigenic strains cause significant disease.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H1391459597">
         <span class="h2">
          Incubation period
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incubation period for shigellosis ranges from one to three days, with an average of two days [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H996709503">
         <span class="h2">
          Signs and symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         The illness typically begins with constitutional symptoms such as fever, anorexia, and malaise. Initially diarrhea is watery, but subsequently may contain blood and mucus. Tenesmus is a common complaint. Nausea and vomiting are notably absent in most patients [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         The frequency of symptoms is as follows [
         <a href="#rid41">
          41-45
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever – 30 to 40 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abdominal pain – 70 to 93 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mucoid diarrhea – 70 to 85 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bloody diarrhea – 35 to 55 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Watery diarrhea – 30 to 40 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vomiting – 35 percent
        </p>
        <p>
        </p>
        <p>
         <em>
          Shigella
         </em>
         is an infection of the colon, particularly the rectosigmoid portion. Stool frequency is typically 8 to 10 per day but may be substantially greater. Significant fluid loss is uncommon (average approximately 30 mL/kg per day). This is in contrast to infections involving the small bowel, which are typified by large volumes of watery diarrhea associated with abdominal cramping, bloating, gas, and weight loss [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         The spectrum of disease severity varies depending on the infecting species.
         <em>
          S. sonnei
         </em>
         commonly causes mild disease, which may be limited to watery diarrhea, whereas
         <em>
          S. flexneri
         </em>
         or
         <em>
          S. dysenteriae
         </em>
         1 commonly cause dysenteric symptoms (bloody diarrhea) [
         <a href="#rid45">
          45,47,48
         </a>
         ]. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
         The disease course is generally self-limited in immunocompetent individuals, lasting no more than seven days (in the absence of antibiotic therapy). The typical disease course varies with age group. In one review including 318 infants and children hospitalized with shigellosis in Bangladesh, infants had fewer days with diarrhea (four versus six) and were more likely to have watery (as opposed to bloody) stools, hyponatremia, abdominal distension, and acidosis than older children [
         <a href="#rid49">
          49
         </a>
         ]. Older children were more likely to have a leukemoid reaction than infants. The mortality rate for infants was twice that of older children.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Intestinal complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Shigella
         </em>
         is an infection of the colon, particularly the rectosigmoid portion. Rarely, intestinal complications can occur in the setting of
         <em>
          Shigella
         </em>
         infection (
         <a class="graphic graphic_table graphicRef69134" href="/z/d/graphic/69134.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Proctitis or rectal prolapse
         </strong>
         – In infants and young children, severe inflammation of the rectum and distal colon induced by organism invasion into the colonic mucosa may lead to proctitis or rectal prolapse [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Toxic megacolon
         </strong>
         – Toxic megacolon occurs primarily in the setting of
         <em>
          S. dysenteriae
         </em>
         1 infection. The pathogenesis of this complication is uncertain; it occurs in the setting of pancolitis and seems to be related to the intensity of inflammation rather than being mediated by
         <em>
          Shiga
         </em>
         toxin. In one study, the incidence of toxic megacolon among patients with diarrhea in Bangladesh was 3 percent [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intestinal obstruction
         </strong>
         – Severe colonic disease may result in intestinal obstruction. In one series of 1211 patients with shigellosis, the incidence was 2.5 percent [
         <a href="#rid50">
          50
         </a>
         ]. The patients with obstruction were more likely to be infected with
         <em>
          S. dysenteriae
         </em>
         1 and were more severely ill, with higher white blood cell count and lower serum sodium concentration.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Colonic perforation
         </strong>
         – Colonic perforation is an extremely rare complication of shigellosis; it occurs principally in infants or severely malnourished patients and is associated with infection due to
         <em>
          S. dysenteriae
         </em>
         1 or
         <em>
          S. flexneri
         </em>
         . In one epidemic of
         <em>
          S. dysenteriae
         </em>
         1 in Central America, colonic perforation was seen at autopsy in 1.7 percent of cases [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Systemic complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Shigellosis may be associated with a number of systemic complications (
         <a class="graphic graphic_table graphicRef69134" href="/z/d/graphic/69134.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Bacteremia
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of bacteremia has been reported to be 0 to 7 percent [
         <a href="#rid52">
          52-55
         </a>
         ]. Signs that may occur in the setting of bacteremia include leukocytosis, hypothermia or temperature &gt;39.5°C, severe dehydration, and lethargy [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Bacteremia is more common among children &lt;5 years of age and adults &gt;65 years than among older children or younger adults [
         <a href="#rid52">
          52,55,56
         </a>
         ]. Among 22 cases of bacteremia described among adults, one-third of patients were older than 65 years of age, and more than half had an underlying disease (most commonly diabetes) [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
         HIV infection does not appear to confer significant predisposition to
         <em>
          Shigella
         </em>
         bacteremia. Among adults in Soweto, South Africa, the rate of HIV infection nearly doubled between 1996 and 2006, while the rate of
         <em>
          Shigella
         </em>
         bacteremia remained stable (approximately 0.2 per 1000 adults; 0.8 per 100 children) [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         Bacteremia is associated with an increased risk of death [
         <a href="#rid55">
          55
         </a>
         ]. Young, malnourished children are at greatest risk. Additionally, the mortality rate associated with
         <em>
          Shigella
         </em>
         bacteremia may be higher in the setting of HIV infection. In a study of systemic shigellosis in South Africa, patients with HIV infection were more likely to die than patients without HIV infection (29 of 78 versus 5 of 40 of cases were fatal, respectively) [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Fluid, electrolyte, and nutrition disturbances
         </span>
         <span class="headingEndMark">
          —
         </span>
         Substantial volume depletion is uncommon in shigellosis because the stool volume is usually low. In one review of 412 patients with shigellosis, 36 percent had mild dehydration, 12 percent had moderate dehydration, and 2 percent had severe dehydration [
         <a href="#rid41">
          41
         </a>
         ]. In another series, hyponatremia (serum sodium &lt;120 mEq/L) was observed in 29 percent of patients hospitalized with diarrhea due to
         <em>
          S. dysenteriae
         </em>
         1 [
         <a href="#rid58">
          58
         </a>
         ]. Hyponatremia is generally due to the syndrome of inappropriate antidiuretic hormone secretion, not volume depletion [
         <a href="#rid15">
          15,58
         </a>
         ].
        </p>
        <p>
         Protein-losing enteropathy may be observed. In one report that used stool alpha-1 antitrypsin levels as an indicator of protein excretion, protein loss was high during the acute phase in patients with dysentery (bloody diarrhea), remained high in patients who failed treatment, and fell to normal values in those who were recovered [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         Increased catabolism due to fever, stool protein loss, malabsorption, and decreased intake associated with anorexia can exacerbate pre-existing malnutrition.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Leukemoid reaction
         </span>
         <span class="headingEndMark">
          —
         </span>
         A leukemoid reaction (white blood count ≥50,000/mm
         <sup>
          3
         </sup>
         or more) has been observed in Bangladesh among approximately 4 percent of patients, most commonly in children between 2 and 10 years of age (and not at all in children younger &lt;1 year of age) [
         <a href="#rid60">
          60
         </a>
         ]. The white blood cell count in these patients ranged from 50,000 to 195,000/mm
         <sup>
          3
         </sup>
         and was accompanied by an increased number of immature forms. In this study, the mortality rate also was increased among patients with a leukemoid reaction (21 versus 7 percent).
        </p>
        <p>
         In contrast, a study conducted in the United States found no association between disease severity and a high white blood cell count [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Neurologic disease
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seizures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Epidemiology
         </strong>
         – Seizures are the most common neurologic complication associated with
         <em>
          Shigella
         </em>
         infection and occur almost exclusively among children &lt;15 years of age. In one study including 68 children hospitalized for acute gastroenteritis with convulsions,
         <em>
          Shigella
         </em>
         infection was associated with increased risk of seizures (odds ratio 3.38, 95% CI 1.50-7.59) [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Seizures tend to be generalized and are not associated with specific neurologic deficits, but have been associated with a higher risk of death [
         <a href="#rid62">
          62,63
         </a>
         ]. The reported prevalence of seizures among children with shigellosis has ranged from 5 to 45 percent; among patients of all ages hospitalized with shigellosis, the prevalence is about 10 percent [
         <a href="#rid15">
          15,62,63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Seizures have been observed during infection with all serotypes of
         <em>
          Shigella
         </em>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Associated clinical and laboratory findings
         </strong>
         – The occurrence of seizures is associated with fever (often greater &gt;39°C [102.2°F]), increased proportion of immature leukocytes, low serum sodium, and high serum potassium. Analysis of cerebrospinal fluid is typically normal; up to 15 percent may have mild lymphocytic pleocytosis with up to 12 cells.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mechanism
         </strong>
         – Neurologic complications of
         <em>
          Shigella
         </em>
         infection were previously thought to be induced by circulating Shiga toxin produced by
         <em>
          S. dysenteriae
         </em>
         1, though this is not likely to be true [
         <a href="#rid37">
          37
         </a>
         ]. In one study including five children with shigellosis and seizures or encephalopathy, cytotoxic activity was not detected in serum or spinal fluid (although it was present in stool, at levels 1000-fold below that of cultured
         <em>
          S. dysenteriae
         </em>
         1) [
         <a href="#rid64">
          64
         </a>
         ]. The stool cytotoxic activity was not neutralized by anti-Shiga toxin antibodies, no patient had neutralizing antibodies to Shiga toxin, and DNA hybridization studies of t
         <em>
          he Shigella
         </em>
         isolates that probed for the gene encoding Shiga toxin were negative.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other neurologic complications
         </strong>
         – Other neurologic findings have been described in up to 40 percent of children hospitalized with
         <em>
          Shigella
         </em>
         infection, including encephalopathy with lethargy, confusion, and headache [
         <a href="#rid65">
          65
         </a>
         ]. Obtundation, coma, and posturing are rare. In cases of fatal encephalopathy, cerebral edema has been observed at autopsy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A particularly lethal form of shigellosis, known as the Ekiri syndrome, was responsible for 15,000 deaths per year in Japan during the pre-World War II era [
         <a href="#rid15">
          15
         </a>
         ]. The Ekiri syndrome was associated with
         <em>
          S. sonnei
         </em>
         infection and was characterized by the rapid development of seizures and coma in patients with high fever and few dysenteric symptoms. The mechanism of the fulminant course remains unclear.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Reactive arthritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reactive arthritis is an uncommon complication that may be observed following
         <em>
          S. flexneri
         </em>
         infection, either alone or in association with conjunctivitis and urethritis. In a study of US military personnel, reactive arthritis occurred in 0.5 percent of cases of
         <em>
          Shigella
         </em>
         gastroenteritis [
         <a href="#rid66">
          66
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">
          "Reactive arthritis"
         </a>
         .)
        </p>
        <p>
         The arthritis is a sterile inflammatory arthritis. Symptoms develop one to two weeks following symptoms of dysentery (bloody diarrhea), regardless of whether antibiotic treatment was administered. Approximately 70 percent of patients with arthritis are HLA-B27 positive [
         <a href="#rid67">
          67
         </a>
         ]. A 5 amino acid peptide encoded on a 2 Md
         <em>
          Shigella
         </em>
         plasmid has been associated with reactive arthritis in two separate studies [
         <a href="#rid68">
          68,69
         </a>
         ]. This peptide has sequence similarity to the HLA B27 alpha 1 domain, suggesting that molecular mimicry may play a pathogenetic role in arthritis. (See
         <a class="medical medical_review" href="/z/d/html/7792.html" rel="external">
          "Pathogenesis of spondyloarthritis"
         </a>
         .)
        </p>
        <p>
         Sterile reactive arthritis has also been described following infection with
         <em>
          Campylobacter jejuni
         </em>
         ,
         <em>
          Salmonella enteritidis
         </em>
         ,
         <em>
          Salmonella typhimurium
         </em>
         ,
         <em>
          Yersinia enterocolitica
         </em>
         , and
         <em>
          Yersinia pseudotuberculosis
         </em>
         [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1936477389">
         <span class="h3">
          Hemolytic-uremic syndrome (HUS)
         </span>
         <span class="headingEndMark">
          —
         </span>
         HUS has been described most commonly in the context of infection due to Shiga toxin-producing
         <em>
          Escherichia coli
         </em>
         (STEC) infections; less frequently, it has also been associated with
         <em>
          Shigella dysenteriae
         </em>
         type 1 infection [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         Retrospective data suggest that antibiotic use in the setting of
         <em>
          S. dysenteriae
         </em>
         1 infection does not induce development of HUS, and that treatment with antibiotics may reduce its likelihood. In a review of several studies including 128 adults and 250 children with
         <em>
          S. dysenteriae
         </em>
         1 infection treated with antibiotics, one child developed HUS [
         <a href="#rid72">
          72
         </a>
         ]. The increased risk of HUS with antibiotic treatment for STEC infection but not
         <em>
          S. dysenteriae
         </em>
         1 infection may be due to a difference in the genomes of these two organisms. In
         <em>
          S. dysenteriae
         </em>
         1, the phage that carries the Shiga toxin genes is unable to undergo lysogenic conversion, whereas the phage that carries these genes within pathogenic
         <em>
          E. coli
         </em>
         is not defective [
         <a href="#rid73">
          73,74
         </a>
         ].
        </p>
        <p>
         Issues related to hemolytic-uremic syndrome are discussed further separately. (See
         <a class="medical medical_review" href="/z/d/html/89549.html" rel="external">
          "Overview of hemolytic uremic syndrome in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114693.html" rel="external">
          "Thrombotic microangiopathies (TMAs) with acute kidney injury (AKI) in adults: CM-TMA and ST-HUS"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H996709308">
         <span class="h2">
          Other manifestations
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vaginitis or vulvovaginitis
         </strong>
         – In young girls,
         <em>
          Shigella
         </em>
         can cause vaginitis or vulvovaginitis, with or without diarrhea [
         <a href="#rid75">
          75
         </a>
         ]. The vaginal discharge is usually painless and may be bloody. Symptoms may persist for several months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Keratitis
         </strong>
         –
         <em>
          Shigella
         </em>
         is a rare cause of keratitis; it should be considered as the cause of keratitis or conjunctivitis in young children with recent diarrheal illness or exposure [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Myocarditis
         </strong>
         – Acute myocarditis has been associated with acute
         <em>
          S. sonnei
         </em>
         gastroenteritis in two children [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H2782513217">
         <span class="h2">
          Clinical suspicion
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Shigella
         </em>
         should be suspected in the setting of relevant clinical manifestations (watery or bloody diarrhea, abdominal pain, tenesmus, and fever). These manifestations may occur in the presence or absence of relevant epidemiologic exposure, such as contact with an individual with recent shigellosis (such as a household member, a member of a residential institution, or sexual partner) or exposure to food or water implicated in a shigellosis outbreak.
        </p>
        <p>
         Presence of white blood cells and red blood cells on direct microscopic stool examination (if available; this test is no longer performed in many laboratories) should also raise suspicion for
         <em>
          Shigella
         </em>
         infection.
        </p>
        <p class="headingAnchor" id="H415677214">
         <span class="h2">
          Diagnostic evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stool culture is the preferred tool for diagnosis of
         <em>
          Shigella
         </em>
         since it provides an isolate for subsequent susceptibility testing. Stool molecular panels are capable of detecting an array of bacterial pathogens; however, they are not able to assess antimicrobial susceptibility of the identified pathogens. Therefore, if
         <em>
          Shigella
         </em>
         is identified via molecular testing, reflex culture and susceptibility testing should be performed. (See
         <a class="local">
          'Antimicrobial susceptibility testing'
         </a>
         below.)
        </p>
        <p>
         For patients with
         <em>
          Shigella
         </em>
         infection associated with sexual transmission, evaluation for other sexually transmitted infections should also be pursued. (See
         <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">
          "Screening for sexually transmitted infections"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stool culture
         </strong>
         –
         <em>
          Shigella
         </em>
         is a fastidious organism; it requires prompt handling and optimally should be inoculated onto agar at the bedside or soon after collection. A stool culture may have higher yield than culture from a rectal swab; the best yield is from a mucoid part of stool [
         <a href="#rid78">
          78
         </a>
         ]. If transport is required, the best medium is buffered glycerol
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         (BGS) [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <em>
          Shigella
         </em>
         is cultured by routine techniques in most clinical microbiology laboratories. Initial inoculation should be on more than one low selectivity medium, such as MacConkey or eosin
         <a class="drug drug_general" data-topicid="9636" href="/z/d/drug information/9636.html" rel="external">
          methylene blue
         </a>
         . Colonies that appear suspicious on low selectivity media are usually subcultured onto highly selective media such as SS (
         <em>
          Salmonella
         </em>
         -
         <em>
          Shigella
         </em>
         ), XLD (xylose-lysine-deoxycholate), HE (hektoen enteric), or deoxycholate citrate agar (
         <a class="graphic graphic_picture graphicRef81081" href="/z/d/graphic/81081.html" rel="external">
          picture 1
         </a>
         ). All these media contain lactose, as well as a color indicator.
         <em>
          Shigella
         </em>
         do not ferment lactose (they are lactose non-fermenters).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Further classification can be pursued including identification of serogroup and serotype, although these are rarely important to clinical management, and these studies are not performed in most clinical laboratories.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Molecular testing
         </strong>
         – A variety of molecular diagnostics techniques, including multiplex molecular panels, may be used for detection of
         <em>
          Shigella
         </em>
         in stool [
         <a href="#rid80">
          80
         </a>
         ]. Polymerase chain reaction has been used to detect
         <em>
          Shigella
         </em>
         -specific DNA sequences, frequently a group of
         <em>
          Shigella
         </em>
         -specific genes known as invasion plasmid antigen H (ipaH), which enables the detection of as few as 10 to 100
         <em>
          S. flexneri
         </em>
         organisms (as compared with 10(6) organisms detected by routine culture) [
         <a href="#rid81">
          81,82
         </a>
         ]. These molecular assays are becoming increasingly available in clinical laboratories [
         <a href="#rid80">
          80,83
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H428318760">
         <span class="h2">
          Antimicrobial susceptibility testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antimicrobial susceptibility testing should be performed on all
         <em>
          Shigella
         </em>
         isolates to inform antibiotic selection. Identifying drug-resistant infections can also inform appropriate public health measures. (See
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults", section on 'Antibiotic resistance'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6003.html" rel="external">
          "Shigella infection: Treatment and prevention in children", section on 'Antibiotic resistance'
         </a>
         .)
        </p>
        <p>
         Antimicrobial susceptibility testing is especially important for
         <em>
          Shigella
         </em>
         infections because of the rising rate of antimicrobial resistance. In particular, susceptibility testing for
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         should assess drug dilutions of 0.12 mcg/mL or lower, and clinicians should request the minimum inhibitory concentration (MIC) to ciprofloxacin if it is not routinely provided with the susceptibility testing results [
         <a href="#rid84">
          84
         </a>
         ].
        </p>
        <p>
         Issues related to antibiotic resistance are discussed further separately. (See
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults", section on 'Antibiotic resistance'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults", section on 'Directed therapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2109771922">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis for
         <em>
          Shigella
         </em>
         infection includes infection with
         <em>
          Salmonella
         </em>
         ,
         <em>
          Campylobacter
         </em>
         ,
         <em>
          Yersinia
         </em>
         , enteroinvasive
         <em>
          E. coli
         </em>
         ,
         <em>
          E. histolytica
         </em>
         , or
         <em>
          Clostridioides
         </em>
         <em>
          difficile
         </em>
         , as well as noninfectious inflammatory bowel disease [
         <a href="#rid85">
          85
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2717.html" rel="external">
          "Approach to the adult with acute diarrhea in resource-abundant settings"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13954.html" rel="external">
          "Approach to the adult with acute diarrhea in resource-limited settings"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6456.html" rel="external">
          "Diagnostic approach to diarrhea in children in resource-abundant settings"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13956.html" rel="external">
          "Approach to the child with acute diarrhea in resource-limited settings"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H748779222">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109942.html" rel="external">
          "Society guideline links: Acute diarrhea in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H996708448">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Burden of disease
         </strong>
         –
         <em>
          Shigella
         </em>
         species are a common cause of diarrhea worldwide, and a major cause of morbidity and mortality.
         <em>
          Shigella
         </em>
         is the most common cause of invasive (bloody) diarrhea among children in resource-limited settings. (See
         <a class="local">
          'Burden of disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Transmission
         </strong>
         (see
         <a class="local">
          'Transmission'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <em>
          Shigella
         </em>
         organisms can survive transit through the stomach since they are less susceptible to acid than other bacteria. For this reason, the inoculum required for the development of clinical disease is quite low; as few as 10 to 100 organisms can cause disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <em>
          Shigella
         </em>
         bacteria are transmitted by the fecal-oral route; this includes transmission within households or between close contacts, transmission through sexual contact, and outbreaks related to contaminated food and water.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Drug resistance
         </strong>
         –
         <em>
          Shigella
         </em>
         species have emerged with resistance to several antibiotics. Issues related to antimicrobial resistance are discussed further separately. (See
         <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">
          "Shigella infection: Treatment and prevention in adults", section on 'Antibiotic resistance'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         (see
         <a class="local">
          'Microbiology'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Species
         </strong>
         –
         <strong>
         </strong>
         <em>
          Shigella
         </em>
         are nonmotile, facultatively anaerobic, gram-negative rods. There are four species:
         <em>
          S. dysenteriae
         </em>
         ,
         <em>
          S. flexneri
         </em>
         ,
         <em>
          Shigella boydii
         </em>
         , and
         <em>
          S. sonnei
         </em>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Geographic variability
         </strong>
         – In many resource-limited settings,
         <em>
          S. flexneri
         </em>
         is the predominant species;
         <em>
          S. sonnei
         </em>
         is the second most prevalent. In the United States, most cases are caused by
         <em>
          S. sonnei
         </em>
         ;
         <em>
          S. flexneri
         </em>
         is the next most frequent isolate.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Association with disease severity
         </strong>
         –
         <em>
          S. sonnei
         </em>
         commonly causes mild disease, which may be limited to watery diarrhea, whereas
         <em>
          S. flexneri
         </em>
         or
         <em>
          S. dysenteriae
         </em>
         1 commonly cause invasive (bloody) diarrhea.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Incubation period
         </strong>
         –
         <strong>
         </strong>
         The incubation period for shigellosis ranges from one to three days. (See
         <a class="local">
          'Incubation period'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Signs and symptoms
         </strong>
         – Symptoms include diarrhea (watery or bloody), abdominal pain, tenesmus, and fever. The disease course is generally self-limited in immunocompetent individuals, lasting no more than seven days (in the absence of antibiotic therapy). (See
         <a class="local">
          'Signs and symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Complications
         </strong>
         (
         <a class="graphic graphic_table graphicRef69134" href="/z/d/graphic/69134.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Intestinal complications
         </strong>
         – Intestinal complications of
         <em>
          Shigella
         </em>
         infection include proctitis, rectal prolapse, toxic megacolon, intestinal obstruction, and colonic perforation. (See
         <a class="local">
          'Intestinal complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Systemic complications
         </strong>
         – Systemic complications of
         <em>
          Shigella
         </em>
         infection include bacteremia, fluid/electrolyte/nutrition disturbances, leukemoid reaction, neurologic disease (seizures, encephalopathy), and reactive arthritis. Infrequently, hemolytic uremic syndrome has been associated with
         <em>
          Shigella dysenteriae
         </em>
         type 1 infection. (See
         <a class="local">
          'Systemic complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical suspicion
         </strong>
         –
         <em>
          Shigella
         </em>
         should be suspected in the setting of relevant clinical manifestations, which may occur in the presence or absence of relevant epidemiologic exposure. (See
         <a class="local">
          'Clinical suspicion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnostic evaluation
         </strong>
         – Stool culture is the preferred tool for diagnosis of
         <em>
          Shigella
         </em>
         since it provides an isolate for subsequent susceptibility testing. Stool molecular panels are capable of detecting an array of bacterial pathogens; however, they are not able to assess antimicrobial susceptibility of the identified pathogens. Therefore, if
         <em>
          Shigella
         </em>
         is identified via molecular testing, reflex culture and susceptibility testing should be performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For patients with
         <em>
          Shigella
         </em>
         infection associated with sexual transmission, evaluation for other sexually transmitted infections should also be pursued. (See
         <a class="local">
          'Diagnostic evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Antimicrobial susceptibility testing
         </strong>
         – Antimicrobial susceptibility testing is especially important for
         <em>
          Shigella
         </em>
         infection because of the rising rate of antimicrobial resistance. In particular,
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         susceptibility testing should assess drug dilutions of 0.12 mcg/mL or lower, and clinicians should request the minimum inhibitory concentration (MIC) for ciprofloxacin if it is not routinely provided with the susceptibility testing results. (See
         <a class="local">
          'Antimicrobial susceptibility testing'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kotloff KL, Riddle MS, Platts-Mills JA, et al. Shigellosis. Lancet 2018; 391:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu J, Platts-Mills JA, Juma J, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 2016; 388:1291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosek M, Yori PP, Pan WK, et al. Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics 2008; 122:e541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Livio S, Strockbine NA, Panchalingam S, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis 2014; 59:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker S, The HC. Recent insights into Shigella. Curr Opin Infect Dis 2018; 31:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vinh H, Nhu NT, Nga TV, et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 2009; 9:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt KE, Thieu Nga TV, Thanh DP, et al. Tracking the establishment of local endemic populations of an emergent enteric pathogen. Proc Natl Acad Sci U S A 2013; 110:17522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joh RI, Hoekstra RM, Barzilay EJ, et al. Dynamics of shigellosis epidemics: estimating individual-level transmission and reporting rates from national epidemiologic data sets. Am J Epidemiol 2013; 178:1319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Libby T, Clogher P, Wilson E, et al. Disparities in Shigellosis Incidence by Census Tract Poverty, Crowding, and Race/Ethnicity in the United States, FoodNet, 2004-2014. Open Forum Infect Dis 2020; 7:ofaa030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delahoy MJ, Shah HJ, Weller DL, et al. Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022. MMWR Morb Mortal Wkly Rep 2023; 72:701.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention (CDC). National Shigella Surveillance Annual Report, 2012. Atlanta, Georgia: US Department of Health and Human Services, CDC, 2014.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shad AA, Shad WA. Shigella sonnei: virulence and antibiotic resistance. Arch Microbiol 2021; 203:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsonnet J, Greene KD, Gerber AR, et al. Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. Lancet 1989; 2:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kolavic SA, Kimura A, Simons SL, et al. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination. JAMA 1997; 278:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennish ML. Potentially lethal complications of shigellosis. Rev Infect Dis 1991; 13 Suppl 4:S319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson R, Feldman RA, Davis J, LaVenture M. Family illness associated with Shigella infection: the interrelationship of age of the index patient and the age of household members in acquisition of illness. J Infect Dis 1981; 143:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MOSLEY WH, ADAMS B, LYMAN ED. Epidemiologic and sociologic features of a large urban outbreak of shigellosis. JAMA 1962; 182:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Day care-related outbreaks of rhamnose-negative Shigella sonnei--six states, June 2001-March 2003. MMWR Morb Mortal Wkly Rep 2004; 53:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Shigella flexneri serotype 3 infections among men who have sex with men--Chicago, Illinois, 2003-2004. MMWR Morb Mortal Wkly Rep 2005; 54:820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hines JZ, Pinsent T, Rees K, et al. Notes from the Field: Shigellosis Outbreak Among Men Who Have Sex with Men and Homeless Persons - Oregon, 2015-2016. MMWR Morb Mortal Wkly Rep 2016; 65:812.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowen A, Eikmeier D, Talley P, et al. Notes from the Field: Outbreaks of Shigella sonnei Infection with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men - Chicago and Metropolitan Minneapolis-St. Paul, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:597.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McNeil CJ, Kirkcaldy RD, Workowski K. Enteric Infections in Men Who Have Sex With Men. Clin Infect Dis 2022; 74:S169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newman KL, Newman GS, Cybulski RJ, Fang FC. Gastroenteritis in Men Who Have Sex With Men in Seattle, Washington, 2017-2018. Clin Infect Dis 2020; 71:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toro C, Arroyo A, Sarria A, et al. Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance. Am J Trop Med Hyg 2015; 93:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker KS, Dallman TJ, Ashton PM, et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study. Lancet Infect Dis 2015; 15:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowen A, Grass J, Bicknese A, et al. Elevated Risk for Antimicrobial Drug-Resistant Shigella Infection among Men Who Have Sex with Men, United States, 2011-2015. Emerg Infect Dis 2016; 22:1613.
          </a>
         </li>
         <li class="breakAll">
          CDC Health Alert Network. Increase in Extensively Drug-Resistant Shigellosis in the United States (2023) https://emergency.cdc.gov/han/2023/han00486.asp (Accessed on June 07, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lefèvre S, Njamkepo E, Feldman S, et al. Rapid emergence of extensively drug-resistant Shigella sonnei in France. Nat Commun 2023; 14:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charles H, Prochazka M, Thorley K, et al. Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021-22: a descriptive epidemiological study. Lancet Infect Dis 2022; 22:1503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aluko SK, Ishrati SS, Walker DC, et al. Outbreaks of Acute Gastrointestinal Illness Associated with a Splash Pad in a Wildlife Park - Kansas, June 2021. MMWR Morb Mortal Wkly Rep 2022; 71:981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Painter JA, Hoekstra RM, Ayers T, et al. Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008. Emerg Infect Dis 2013; 19:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graciaa DS, Cope JR, Roberts VA, et al. Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2018; 67:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nataro JP, Seriwatana J, Fasano A, et al. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun 1995; 63:4721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noriega FR, Liao FM, Formal SB, et al. Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J Infect Dis 1995; 172:1408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fasano A, Noriega FR, Maneval DR Jr, et al. Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest 1995; 95:2853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fasano A, Noriega FR, Liao FM, et al. Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 1997; 40:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keusch GT, Donohue-Rolfe A, Jacewicz M. Shigella toxin(s): description and role in diarrhea and dysentery. Pharmacol Ther 1981; 15:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamba K, Nelson JA, Kimura AC, et al. Shiga Toxin 1-Producing Shigella sonnei Infections, California, United States, 2014-2015. Emerg Infect Dis 2016; 22:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gray MD, Lampel KA, Strockbine NA, et al. Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola. Emerg Infect Dis 2014; 20:1669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chai SJ, Gu W, O'Connor KA, et al. Incubation periods of enteric illnesses in foodborne outbreaks, United States, 1998-2013. Epidemiol Infect 2019; 147:e285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll BJ, Glass RI, Huq MI, et al. Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh. J Infect Dis 1982; 146:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barrett-Connor E, Connor JD. Extraintestinal manifestations of shigellosis. Am J Gastroenterol 1970; 53:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Echeverria P, Sethabutr O, Pitarangsi C. Microbiology and diagnosis of infections with Shigella and enteroinvasive Escherichia coli. Rev Infect Dis 1991; 13 Suppl 4:S220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DuPont HL, Hornick RB, Dawkins AT, et al. The response of man to virulent Shigella flexneri 2a. J Infect Dis 1969; 119:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan WA, Griffiths JK, Bennish ML. Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic. PLoS One 2013; 8:e64097.
          </a>
         </li>
         <li class="breakAll">
          Acheson DW, Keusch GT. Shigella and enteroinvasive Escherichia coli. In: Infections of the Gastrointestinal Tract, Blaser MJ, Smith PD, Ravdin JI, et al (Eds), Raven Press, New York 1995. p.765.
         </li>
         <li class="breakAll">
          Keusch GT, Formal SB, Bennish ML. Shigellosis. In: Tropical and Geographical Medicine, Warren KS, Mahmoud AAF (Eds), McGraw-Hill, New York 1990. p.763.
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCrickard LS, Crim SM, Kim S, Bowen A. Disparities in severe shigellosis among adults - Foodborne diseases active surveillance network, 2002-2014. BMC Public Health 2018; 18:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huskins WC, Griffiths JK, Faruque AS, Bennish ML. Shigellosis in neonates and young infants. J Pediatr 1994; 125:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennish ML, Azad AK, Yousefzadeh D. Intestinal obstruction during shigellosis: incidence, clinical features, risk factors, and outcome. Gastroenterology 1991; 101:626.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azad MA, Islam M, Butler T. Colonic perforation in Shigella dysenteriae 1 infection. Pediatr Infect Dis 1986; 5:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin T, Habbick BF, Nyssen J. Shigellosis with bacteremia: a report of two cases and a review of the literature. Pediatr Infect Dis 1983; 2:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hawkins C, Taiwo B, Bolon M, et al. Shigella sonnei bacteremia: two adult cases and review of the literature. Scand J Infect Dis 2007; 39:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morduchowicz G, Huminer D, Siegman-Igra Y, et al. Shigella bacteremia in adults. A report of five cases and review of the literature. Arch Intern Med 1987; 147:2034.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Struelens MJ, Patte D, Kabir I, et al. Shigella septicemia: prevalence, presentation, risk factors, and outcome. J Infect Dis 1985; 152:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davies NE, Karstaedt AS. Shigella bacteraemia over a decade in Soweto, South Africa. Trans R Soc Trop Med Hyg 2008; 102:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keddy KH, Sooka A, Crowther-Gibson P, et al. Systemic shigellosis in South Africa. Clin Infect Dis 2012; 54:1448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keusch GT, Bennish ML. Shigellosis: recent progress, persisting problems and research issues. Pediatr Infect Dis J 1989; 8:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennish ML, Salam MA, Wahed MA. Enteric protein loss during shigellosis. Am J Gastroenterol 1993; 88:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butler T, Islam MR, Bardhan PK. The leukemoid reaction in shigellosis. Am J Dis Child 1984; 138:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iflah M, Kassem E, Rubinstein U, et al. Convulsions in children hospitalized for acute gastroenteritis. Sci Rep 2021; 11:15874.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashkenazi S, Dinari G, Zevulunov A, Nitzan M. Convulsions in childhood shigellosis. Clinical and laboratory features in 153 children. Am J Dis Child 1987; 141:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan WA, Dhar U, Salam MA, et al. Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome. Pediatrics 1999; 103:E18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashkenazi S, Cleary KR, Pickering LK, et al. The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis. J Infect Dis 1990; 161:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Avital A, Maayan C, Goitein KJ. Incidence of convulsions and encephalopathy in childhood Shigella infections. Survey of 117 hospitalized patients. Clin Pediatr (Phila) 1982; 21:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter CK, Choi D, Riddle MS. Pathogen-specific risk of reactive arthritis from bacterial causes of foodborne illness. J Rheumatol 2013; 40:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simon DG, Kaslow RA, Rosenbaum J, et al. Reiter's syndrome following epidemic shigellosis. J Rheumatol 1981; 8:969.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stieglitz H, Lipsky P. Association between reactive arthritis and antecedent infection with Shigella flexneri carrying a 2-Md plasmid and encoding an HLA-B27 mimetic epitope. Arthritis Rheum 1993; 36:1387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adam T, Siewerdt R, Offermann I, et al. Prevalence and molecular diversity of pHS-2 plasmids, marker for arthritogenicity, among clinical Escherichia coli Shigella isolates. Microbes Infect 2003; 5:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes RA, Keat AC. Reiter's syndrome and reactive arthritis: a current view. Semin Arthritis Rheum 1994; 24:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butler T. Haemolytic uraemic syndrome during shigellosis. Trans R Soc Trop Med Hyg 2012; 106:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennish ML, Khan WA, Begum M, et al. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. Clin Infect Dis 2006; 42:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonough MA, Butterton JR. Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1. Mol Microbiol 1999; 34:1058.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greco KM, McDonough MA, Butterton JR. Variation in the Shiga toxin region of 20th-century epidemic and endemic Shigella dysenteriae 1 strains. J Infect Dis 2004; 190:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy TV, Nelson JD. Shigella vaginitis: report of 38 patients and review of the literature. Pediatrics 1979; 63:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tobias JD, Starke JR, Tosi MF. Shigella keratitis: a report of two cases and a review of the literature. Pediatr Infect Dis J 1987; 6:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubenstein JS, Noah ZL, Zales VR, Shulman ST. Acute myocarditis associated with Shigella sonnei gastroenteritis. J Pediatr 1993; 122:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahaman MM, Huq I, Dey CR. Superiority of MacConkey's agar over salmonella-shigella agar for isolation of Shigella dysenteriae type 1. J Infect Dis 1975; 131:700.
          </a>
         </li>
         <li class="breakAll">
          Farmer JJ, Wells JG, Griffin PM. Enterobacteriaceae infections. In: Diagnostic Procedures for Bacterial Infections, Wentworth BB (Ed), American Public Health Association, Washington, DC 1987. p.274.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Platts-Mills JA, Rogawski McQuade ET. Shigellosis in young children in low-income and middle-income countries: insights from molecular diagnostics. Curr Opin Infect Dis 2021; 34:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frankel G, Riley L, Giron JA, et al. Detection of Shigella in feces using DNA amplification. J Infect Dis 1990; 161:1252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koziel M, Kiely R, Blake L, et al. Improved detection of bacterial pathogens in patients presenting with gastroenteritis by use of the EntericBio real-time Gastro Panel I assay. J Clin Microbiol 2013; 51:2679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaudio PA, Sethabutr O, Echeverria P, Hoge CW. Utility of a polymerase chain reaction diagnostic system in a study of the epidemiology of shigellosis among dysentery patients, family contacts, and well controls living in a shigellosis-endemic area. J Infect Dis 1997; 176:1013.
          </a>
         </li>
         <li class="breakAll">
          CDC Health Alert Network. CDC Recommendations for Diagnosing and Managing Shigella Strains with Possible Reduced Susceptibility to Ciprofloxacin. April 18, 2017. https://emergency.cdc.gov/han/han00401.asp (Accessed on April 24, 2017).
         </li>
         <li>
          <a class="nounderline abstract_t">
           DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989; 159:1126.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2718 Version 37.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29254859" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27673470" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18710884" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24958238" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Shigella isolates from the global enteric multicenter study inform vaccine development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30048255" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Recent insights into Shigella.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20003464" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24082120" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Tracking the establishment of local endemic populations of an emergent enteric pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24008913" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Dynamics of shigellosis epidemics: estimating individual-level transmission and reporting rates from national epidemiologic data sets.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32099844" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Disparities in Shigellosis Incidence by Census Tract Poverty, Crowding, and Race/Ethnicity in the United States, FoodNet, 2004-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37384552" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37384552" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32929595" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Shigella sonnei: virulence and antibiotic resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2570242" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9244331" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2047657" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Potentially lethal complications of shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7217710" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Family illness associated with Shigella infection: the interrelationship of age of the index patient and the age of household members in acquisition of illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13936184" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Epidemiologic and sociologic features of a large urban outbreak of shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14749615" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Day care-related outbreaks of rhamnose-negative Shigella sonnei--six states, June 2001-March 2003.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16121121" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Shigella flexneri serotype 3 infections among men who have sex with men--Chicago, Illinois, 2003-2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27513523" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Notes from the Field: Shigellosis Outbreak Among Men Who Have Sex with Men and Homeless Persons - Oregon, 2015-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26042652" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Notes from the Field: Outbreaks of Shigella sonnei Infection with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men - Chicago and Metropolitan Minneapolis-St. Paul, 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35416972" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Enteric Infections in Men Who Have Sex With Men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31621824" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Gastroenteritis in Men Who Have Sex With Men in Seattle, Washington, 2017-2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26195465" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25936611" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27533624" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Elevated Risk for Antimicrobial Drug-Resistant Shigella Infection among Men Who Have Sex with Men, United States, 2011-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27533624" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Elevated Risk for Antimicrobial Drug-Resistant Shigella Infection among Men Who Have Sex with Men, United States, 2011-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36709320" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Rapid emergence of extensively drug-resistant Shigella sonnei in France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35809593" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK, 2021-22: a descriptive epidemiological study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35925806" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Outbreaks of Acute Gastrointestinal Illness Associated with a Splash Pad in a Wildlife Park - Kansas, June 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23622497" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29953425" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7591128" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7594690" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7769126" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9176079" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7048347" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Shigella toxin(s): description and role in diarrhea and dysentery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26982255" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Shiga Toxin 1-Producing Shigella sonnei Infections, California, United States, 2014-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25271406" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31587689" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Incubation periods of enteric illnesses in foodborne outbreaks, United States, 1998-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7108270" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5435635" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Extraintestinal manifestations of shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2047641" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Microbiology and diagnosis of infections with Shigella and enteroinvasive Escherichia coli.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5780532" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The response of man to virulent Shigella flexneri 2a.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23691156" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23691156" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23691156" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Gastrointestinal and extra-intestinal manifestations of childhood shigellosis in a region where all four species of Shigella are endemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29415691" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Disparities in severe shigellosis among adults - Foodborne diseases active surveillance network, 2002-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8021764" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Shigellosis in neonates and young infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1860627" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Intestinal obstruction during shigellosis: incidence, clinical features, risk factors, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3511451" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Colonic perforation in Shigella dysenteriae 1 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6340078" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Shigellosis with bacteremia: a report of two cases and a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17366038" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Shigella sonnei bacteremia: two adult cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3314766" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Shigella bacteremia in adults. A report of five cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4045231" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Shigella septicemia: prevalence, presentation, risk factors, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18550134" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Shigella bacteraemia over a decade in Soweto, South Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22474223" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Systemic shigellosis in South Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2682504" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Shigellosis: recent progress, persisting problems and research issues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8420274" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Enteric protein loss during shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6695872" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The leukemoid reaction in shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34354134" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Convulsions in children hospitalized for acute gastroenteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3544808" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Convulsions in childhood shigellosis. Clinical and laboratory features in 153 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9925864" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2324546" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7127986" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Incidence of convulsions and encephalopathy in childhood Shigella infections. Survey of 117 hospitalized patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23547220" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Pathogen-specific risk of reactive arthritis from bacterial causes of foodborne illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6948959" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Reiter's syndrome following epidemic shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7692858" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Association between reactive arthritis and antecedent infection with Shigella flexneri carrying a 2-Md plasmid and encoding an HLA-B27 mimetic epitope.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12787734" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Prevalence and molecular diversity of pHS-2 plasmids, marker for arthritogenicity, among clinical Escherichia coli Shigella isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7534942" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Reiter's syndrome and reactive arthritis: a current view.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22579556" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Haemolytic uraemic syndrome during shigellosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16392080" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10594830" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15216469" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Variation in the Shiga toxin region of 20th-century epidemic and endemic Shigella dysenteriae 1 strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/375177" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Shigella vaginitis: report of 38 patients and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3547292" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Shigella keratitis: a report of two cases and a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7678291" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Acute myocarditis associated with Shigella sonnei gastroenteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1094073" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Superiority of MacConkey's agar over salmonella-shigella agar for isolation of Shigella dysenteriae type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1094073" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Superiority of MacConkey's agar over salmonella-shigella agar for isolation of Shigella dysenteriae type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34261903" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Shigellosis in young children in low-income and middle-income countries: insights from molecular diagnostics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2189008" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Detection of Shigella in feces using DNA amplification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23761157" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Improved detection of bacterial pathogens in patients presenting with gastroenteritis by use of the EntericBio real-time Gastro Panel I assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9333160" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Utility of a polymerase chain reaction diagnostic system in a study of the epidemiology of shigellosis among dysentery patients, family contacts, and well controls living in a shigellosis-endemic area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9333160" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Utility of a polymerase chain reaction diagnostic system in a study of the epidemiology of shigellosis among dysentery patients, family contacts, and well controls living in a shigellosis-endemic area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2656880" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Inoculum size in shigellosis and implications for expected mode of transmission.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
